Macquarie Group LTD Bausch Health Companies Inc. Transaction History
Macquarie Group LTD
- $90.3 Billion
- Q3 2024
A detailed history of Macquarie Group LTD transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 6,600,000 shares of BHC stock, worth $57.8 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
6,600,000Holding current value
$57.8 Million% of portfolio
0.06%Shares
3 transactions
Others Institutions Holding BHC
# of Institutions
255Shares Held
254MCall Options Held
5.47MPut Options Held
16.4M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$304 Million2.88% of portfolio
-
Goldentree Asset Management LP New York, NY29.4MShares$258 Million21.8% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny26.4MShares$232 Million14.7% of portfolio
-
National Bank Of Canada15.6MShares$137 Million0.18% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$114 Million0.26% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $3.17B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...